Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
Cancer cells reprogramme their metabolism with unclear clinical implications. Here, the authors analyse the expression of metabolic genes across 20 types of solid cancers and find that clinical aggressiveness, poor survival and metastasis are associated with the deregulation of mitochondrial metabol...
Guardado en:
Autores principales: | Edoardo Gaude, Christian Frezza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7c13a69fec74620bf503ac30045849d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
por: Ciara H. O’Flanagan, et al.
Publicado: (2017) -
Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer
por: G. C. Deng, et al.
Publicado: (2021) -
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Benedikt Hoeh, et al.
Publicado: (2021) -
Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer
por: Forsythe A, et al.
Publicado: (2018) -
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
por: Axel Muendlein, et al.
Publicado: (2021)